Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine for Cocaine Dependence
NCT00617201Phase 2Completed
- Start
- Jul 2007
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cocaine dependence comparing Atomoxetine with Placebo (2 arms). Primary endpoint: Percentage of Urine Samples Negative for Cocaine at 12 weeks. Started Jul 2007; status: completed.
02
Drugs
atomoxetine
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT00617201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00617201.